Negotiations continue amid Tecos stadium dispute

website tecos TECOS was an event-driven study designed to assess the long-term CV safety of the addition of sitagliptin to usual care, compared to usual care tecos Tecos scores with the latest results, fixtures and tables View up-to-date results live as they happen

tecos Trial Evaluating Cardiovascular Outcomes with Sitagliptin TECOS randomized 14671 participants with type 2 diabetes and  Top-line results of the TECOS cardiovascular outcomes trial with sitagliptin indicate no increased risk of heart failure with the drug,  TECOS has successfully executed hundreds of designs and construction supervision projects in construction field Engineering the future with Excellent

Share

Share

Link

Turn off sharing Copy link

See all details